AllDocs -> cancers

RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Source: Community Assessment Unit, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health July, 2001 Pancreatic Cancer The American Cancer Society estimates that approximately 29,200 people in the U.S. (14,200 men and 15,000 women) will develop pancreatic cancer in 2001. This disease accounts for approximately 2% of all new cases of cancer in both men and women, but between 5% and 6% of all cancer deaths (ACS, 2001). This discrepancy has been attributed to detection of pancreatic cancer at an advanced stage and the short median survival time for this cancer of approximately three months. Between 1920 and 1965, mortality from this disease increased nearly 200% from 2.9 to 8.2 per 100,000 people. These increases are believed to be due, in part, to improved diagnosis during this time period ...

182 Cryptosporidiosis of the biliary tract mimicking pancreatic cancer in an AIDS patient Criptosporidiose do trato biliar simulando câncer do pâncreas em paciente com AIDS Lenice do Rosário de Souza 1 , Maria Aparecida M. Rodrigues 1 , José Morceli 1 Raphael Kemp and Rinaldo Poncio Mendes 1 ABSTRACT Diarrhea caused by Cryptosporidium sp is frequent in patients with AIDS, but involvement of other organs of the digestive tract is uncommon. We report a case of Cryptosporidium -associated obstruction of the biliary tract mimicking cancer of the head of the pancreas in a 43-year-old woman with AIDS. Key-words: Cryptosporidiosis. AIDS. Biliary tract. Pancreatitis. RESUMO A diarréia causada pelo Cryptosporidium sp é muito freqüente em pacientes com aids, mas o envolvimento de outros ...

PANCREATIC CANCER : Lessons From the Past, Hope for the Future Saturday, June 12, 2004 7:30 am – 12:15pm Gaylord-Cary Room Research Studies Center Roswell Park Cancer Institute Description This program is designed for medical, surgical and radiation oncologists, gastroenterologists, pharmacologists, nurse practitioners, physician assistants and nurses. It will focus on the latest approaches in diagnostic and therapeutic approaches for pancreatic cancer . Discussion topics will include endoscopy, imaging, surgical advances, neoadjuvant treatment, new agents, radiation therapy, pain control and nerve blocks. The program will also include a panel discussion with case presentations. Educational Objectives Following this program, participants should be able to: • Describe recent advances in the diagnosis ...

Consensus Conference Pancreatology 2001;1:416–422 Pancreatic Cancer in Hereditary Pancreatitis: Consensus Guidelines for Prevention, Screening and Treatment Charles D. Ulrich for the Consensus Committees of the European Registry of Hereditary Pancreatic Diseases, the Midwest Multi-Center Pancreatic Study Group and the International Association of Pancreatology University of Cincinnati College of Medicine, Cincinnati, Ohio, USA Charles D. Ulrich, II, MD, FACP, FACG Associate Professor of Medicine, Pathobiology and Molecular Medicine University of Cincinnati College of Medicine, 231 Albert B. Sabin Way MSB Room 6555, ML 0595, Cincinnati, OH 45267-0595 (USA) Tel. +1 513 558 5244, Fax +1 513 558 1744, E-Mail charles.ulrich@uc.edu ABC Fax + 41 61 306 12 34 E-Mail karger@karger.ch www.karger.com © 2001 S. Karger AG, Basel and IAP Accessible online ...

The Board of Directors for the Wayne Fusaro Pancreatic Cancer Research Fund (WFPCRF) recently provided continued support for the research laboratory of David C. Whitcomb, MD PhD at the University of Pittsburgh. The WFPCRF contributed $25,000 to support Dr. Whitcomb’s pancreatic cancer genetics research. Wayne Fusaro fell victim to pancreatic cancer in July 2000 after a short 28-day illness. He was only 51 years old. His wife, Jill, has since founded the WFPCRF in his memory. Wayne is also the father of three children: Dana is the mother of one, Ashley, and works at Highmark Blue Cross/Blue Shield; Gina works at PNC Bank; and Tony works at UniFirst. Wayne was the Assistant County Manager for Pennsylvania’s Allegheny County. He enjoyed volunteering for many organizations, and the WFPCRF strives to continue his charitable work. The WFPCRF holds an annual golf outing and run/walk to raise funds and awareness ...

I would like to register __ player(s) for the tournament Player 1 Player 2 Player 3 Player 4 I have included with my registration slip $15 per player through November 8 ($20 on day of tournament) as the registration fee. I would like to sponsor table(s) at the tournament. $25 table sponsorship (includes table ad spot) $50 table sponsorship (includes 2 registration fees and table ad spot) The name of the business/family I would like to appear on my sponsor table spot is I would like to have a memory board in honor of a family member or friend with Pancreatic Cancer . $25 the name of the person in honor is You will be contacted before November 1 to get information to create the board. I cannot make it to the Jeanne Rose Memorial Domino tournament but would like to make a totally tax-deductible contribution to PanCAN. $10 $25 ...

pancreatic cancer *** NOVEMBER IS PANCREATIC CANCER AWARENESS MONTH *** Hi! We've been busy at TEAM HOPE Hope National Capital area! Now that the big Weekend of Hope is over in Los Angeles, I'd like to focus on some of the things that we've been doing here and that we hope to do in the future. 1. At our October 12 meeting in Virginia, we were fortunate to have Kieran Brune from Johns Hopkins talk with us. A summary of Kieran's remarks and contact information for her are set forth below. 2. We can ALL help create awareness for pancreatic cancer . Some suggestions for awareness and fundraising ideas are listed below. Please consider how YOU can become involved! 3-5. I have a request for assistance by one of our members. I also want to share some information on upcoming activities ...

693 Am J Epidemiol 2004;159:693–701 American Journal of Epidemiology Copyright © 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 159, No. 7 Printed in U.S.A. DOI: 10.1093/aje/kwh081 Pancreatic Cancer and Drinking Water and Dietary Sources of Nitrate and Nitrite Angela Coss 1 , Kenneth P. Cantor 2 , John S. Reif 1 , Charles F. Lynch 3 , and Mary H. Ward 2 1 Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO. 2 Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD. 3 Department of Epidemiology, University ...

Bax-Induction Gene Therapy of Pancreatic Cancer Elissa C. Pirocanac, B.S.,* Rounak Nassirpour, M.S.,* Meng Yang, M.D., Ph.D.,* , † Jinwei Wang, M.D.,† Stephanie R. Nardin, B.S.,‡ Jian Gu, M.D.,‡ Bingliang Fang, M.D.,‡ A. R. Moossa, M.D.,* Robert M. Hoffman, Ph.D.,* , † and Michael Bouvet, M.D.* * Department of Surgery, University of California at San Diego, San Diego, California 92161; † AntiCancer, Inc., San Diego, California 92111; and ‡ Department of Cardiovascular and Thoracic Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 Submitted for publication January 22, 2002; published online July 19, 2002 Background. Bax is a strong pro-apoptotic gene that induces programmed cell death when ex- pressed. Human telomerase reverse transcriptase (hTERT) is the catalytic subunit for telomerase, an enzyme found to be ...

Gene Therapy of Pancreatic Cancer With Green Fluorescent Protein and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Gene Expression Driven by a Human Telomerase Reverse Transcriptase Promoter Matthew H. Katz, MD, Daniel E. Spivack, MD, Shinako Takimoto, BS, Bingliang Fang, MD, PhD, Douglas W. Burton, MS, A. R. Moossa, MD, Robert M. Hoffman, PhD, and Michael Bouvet, MD Background: Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) induces apo- ptosis in malignant cells but not in normal cells. Ad/g-TRAIL, an adenoviral vector in which expression of green fluorescent protein (GFP) and TRAIL is driven by a human telomerase reverse transcriptase promoter, has shown promise as a targeted antitumor agent. Methods: To investigate the effects of TRAIL gene therapy on pancreatic cancer , BxPC-3, MIA-PaCa-2, Panc-1, and ASPC-1 cells were treated with Ad/g-TRAIL. Transfection ...

1 FOR IMMEDIATE RELEASE PANCREATIC CANCER ACTION NETWORK GROWS BY LEAPS AND BOUNDS Patient-Based Advocacy Organization’s Success is Marked by Several Achievements, Including an Innovative Program for Pancreatic Cancer Patients and New Headquarters EL SEGUNDO, Calif. U.S.A. (Aug. 6, 2002)? The Pancreatic Cancer Action Network (PanCAN), the first national patient-based advocacy organization for the pancreatic cancer community, continues to grow by leaps and bounds, making it one of the most significant not-for-profit organizations for the pancreatic cancer community, which includes patients, family, medical researchers and physicians. Several important milestones consisting of an innovative information program for patients, additional team members, and a move to larger headquarters in El Segundo, Calif. mark PanCAN’s growth. PanCAN represents thousands of ...

1 FOR IMMEDIATE RELEASE Los Angeles Resident and Pancreatic Cancer Survivor Receives PanCAN’s “Spirit of Hope Award” EL SEGUNDO, Calif. U.S.A. (Nov. 25, 2002)? The Pancreatic Cancer Action Network (PanCAN) honored Los Angeles resident and pancreatic cancer survivor Charlotte Behrendt with its “Spirit of Hope Award.” The PanCAN award honors the courage of pancreatic cancer patients and their families. The award also recognizes a pancreatic cancer survivor and the hope and inspiration this individual contributes to the fight against the disease. PanCAN is the first, national patient-based advocacy organization for the pancreatic cancer community, including patients, families, medical researchers and physicians. ”Charlotte is an inspiration to other pancreatic cancer patients,” said Julie Fleshman, executive director, PanCAN. “It was her recommendation ...

1 FOR IMMEDIATE RELEASE NOVEMBER IS PANCREATIC CANCER AWARENESS MONTH PanCAN Spreads the Word About the 4 th Leading Cause of Cancer Death in the U.S. for Men and Women EL SEGUNDO, Calif. U.S.A. (Oct. 21, 2002)? During Pancreatic Cancer Awareness Month in November, the Pancreatic Cancer Action Network (PanCAN) is spreading the word to raise awareness and increase research for Pancreatic Cancer , the 4 th leading cause of cancer death in the U.S. for men and women. PanCAN is the first, national patient-based advocacy organization for the pancreatic cancer community, including patients, families, medical researchers and physicians. PanCAN founding CEO Paula Kim said, " Approximately 30,300 people in the United States will be diagnosed with pancreatic cancer this year, and pancreatic cancer ...

pancreatic cancer PanCAN’s Federal Agenda November 7, 2003 Copyright 2003 © Pancreatic Cancer Action Network Julie Pawelczyk, Director of Federal Affairs, PanCAN Thomas Sheridan, President, The Sheridan Group 2 PanCAN’s Mission Specifically, PanCAN advocates for: More research Effective treatments Prevention programs Early detection methods To focus national attention on the need to find a cure for pancreatic cancer . Copyright 2003 © Pancreatic Cancer Action Network 3 Why Focus on Congress? ...

pancreatic cancer PanCAN: Working Together for a Cure! Pancreatic Cancer Action Network, Inc. (PanCAN) Julie Fleshman, JD, MBA,Executive Director Paula Kim, President & Founder Michelle Muething, DPT, Director PALS & Scientific Affairs Patient Symposium November 7, 2003 2 Serving Our Community “Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it’s the only thing that ever has.” Margaret Mead 3 Public Survivors Industry/Corporations Researchers Health Professionals Volunteers Caregivers Government BEFORE ...

pancreatic cancer Genetic Issues in Pancreatic Cancer Teri Brentnall University of Washington Seattle, WA Familial Pancreatic Cancer (FPC) 10% PC patients have positive family history Caused by mutations in genes Some genes cause more than one cancer Hopkins Registry of 362 families Risk of Pancreatic cancer : 4% (familial) vs 0.6% (non-familial) Risk of Non- pancreatic cancer : 27% (familial) vs 12% (non-familial) breast, colon, lung Hruban et al. Ann Onc 1999; 10 Suppl 4: 69-73. Cancers associated with pancreatic cancer Colon cancer Stomach cancer Bladder and urinary tract Ovarian and uterine cancer Cancers associated with Pancreatic Cancer Melanoma ...

Pancreatic Cancer Action Network A Publication of the Pancreatic Cancer Action Network Federal Research Funding Starts with the White House By Rep. Jesse Jackson, Jr. - Page # 3-4 PanCAN Funding Assists Researcher in Pursuit of Early Detection Methods Page # 4 Patient and Liaison Services Page # 5-9 Pancreatic Cancer Awareness Month & Team Hope Activities Page # 10-15 An Evening with the Stars Weekend Page # 18-19 Page 2 Dear PanCAN Friends: It is hard to believe that just five years ago there was no PanCAN. There was no place for pancreatic cancer patients and their families to turn. This year, during our 5th year anniversary celebration, we look back with pride at all we have accomplished, and we take this opportunity to thank all of you for your generous support over ...

pancreatic cancer Advocacy Efforts Pancreatic Cancer Action Network, Inc. (PanCAN) Julie Fleshman, JD, MBA,Executive Director Julie Pawelczyk, MALS, Director of Federal Affairs Patient Symposium November 7, 2003 2 Awareness and Advocacy Create awareness Educate the public PALS to patients and families Generate funds for PanCAN Public Policy Increase research dollars the federal government spends on pancreatic cancer Connecting our efforts and message in Washington D.C. with the constiuents at home Awareness creates the momentum to move research dollars, change public policy and educate the public. How to get additional members involved in your community? 5 Two Approaches PanCAN’s Database and Volunteers Currently exists ...

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:IdKw9tP6uf4J:www.wjgnet.com/1007-9327/10/906.pdf allintitle: pancreatic cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Incidence and Mortality Rate Trends In the United States, pancreatic cancer is the fourth leading cause of cancer -related death in males and the fifth leading cause of cancer death in females. Because it is usually diagnosed at an advanced stage, the survival rate is poor compared to other types of cancer . Unfortunately, there has been little change in overall pancreatic cancer incidence or mortality rates throughout the past three decades. Compared to other racial and ethnic groups, African Americans are the most vulnerable to pancreatic cancer , followed by Whites. It is estimated that approximately $709 million* is spent in the United States each year on treatment of pancreatic cancer . *In 1996 dollars, as determined by Brown, Riley, Schussler, and Etzioni and reported in the National Cancer Institute’s Cancer Progress ...

.. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis Sarah P. Thayer 1 *, Marina Pasca di Magliano 4 *, Patrick W. Heiser 4 , Corinne M. Nielsen 1,2 , Drucilla J. Roberts 2 , Gregory Y. Lauwers 2 , Yan Ping Qi 4 , Stephan Gysin 5 , Carlos Ferna´ndez-del Castillo 1 , Vijay Yajnik 3 , Bozena Antoniu 1 , Martin McMahon 5 , Andrew L. Warshaw 1 & Matthias Hebrok 4 1 Department of Surgery, 2 Department of Pathology, and 3 Gastroenterology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA 4 Diabetes Center, Department of Medicine, and ...

Schwarz, Roderich E. “Targeting TGFbeta in Pancreatic Cancer ” [We plan to test a new and unique approach to treatment of pancreatic cancer by blocking the receptor activity of TGFß, which in several different ways helps the cancer cells to grow.] Pancreatic cancer is the fourth-leading cause of cancer death for both men and women, and only 4% of people affected with it do survive 5 years. Pancreatic cancers have a high rate of genetic changes that affect the function of transforming growth factor beta (TGFß); TGFß is the main downregulator of cell growth in gland-like or duct-lining cells, from which pancreatic cancer cells are derived. The majority of these cancer cells lack one or more proteins which mediate the TGFß signal within the cell, so that its break-like effect on cell growth is lost. In addition, more than half of pancreatic cancer cells ...

14. Cooper, M. K., Porter, J. A., Young, K. E. & Beachy, P. A. Plant-derived and synthetic teratogens inhibit the ability of target tissues to respond to Sonic hedgehog signaling. Science 280, 1603–1607 (1998). 15. Berman, D. M. et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297, 1559–1561 (2002). 16. Ericson, J., Morton, S., Kawakami, A., Roelink, H. & Jessell, T. M. Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 87, 661–673 (1996). 17. Wang, L. C. et al. Conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J. Invest. Dermatol. 114, 901–908 (2000). 18. Fuse, N. et al. Sonic hedgehog protein signals not as a hydrolytic enzyme but as an apparent ligand for patched. Proc. Natl Acad. Sci. USA 96, 10992–10999 (1999). 19. Goodrich, L. V., Milenkovic, L., ...

Let's Make Cancer History 1 8 8 8 9 3 9 - 3 3 3 3 I w w w. c a n c e r. c a Pancreatic Cancer What you need to know Page 2 PANCREATIC CANCER What you need to know Even though we hear about cancer almost every day, when you are diagnosed with cancer you may feel alone and afraid. You may also feel overwhelmed by all the information you are given and by the need to make so many decisions. This publication will give you and your family introductory information you need when you first learn that you have pancreatic cancer . It will help you gain a sense of control and help you work with your healthcare team to choose the best treatments for you. Page 3 1 What is cancer ? Cancer is a disease that ...

(Please Print or Type) ? New Address, Please Change My AACR Mailing Information Last Name First Name M.I. Degree__ Date of Birth// XX Are you an AACR member? ? Yes ? No Member Number: Have you submitted an online abstract? ? Yes ? No If not, do you intend to submit an abstract by May 14, 2004? ? Yes ? No ? I intend to apply for a Scholar-in-Training Award. Deadline for abstracts and letter of recommendation is May 14, 2004. Institution Department Institutional Address Address Continued City State/Province Zip/Postal Code Country (if not U.S.) Telephone FAX E-mail E-mail (continued) ? Check this box if you require special accommodations to participate fully in the meeting. Describe briefly: ...

Nutritional Links to Plausible Mechanisms Underlying Pancreatic Cancer Executive Summary Nutritional Sciences Research Group and Cancer Biomarkers Research Group Division of Cancer Prevention, National Cancer Institute National Institutes of Health, Department of Health and Human Services December 3, 2002 Bethesda, Maryland Page 2 1 Nutritional Links to Plausible Mechanisms Underlying Pancreatic Cancer Nutritional Sciences Research Group and Cancer Biomarkers Research Group Executive Summary I. INTRODUCTION Recent epidemiological and experimental studies suggest that pancreatic cancer may be a form of cancer that is preventable. The NCI’s 2002 Strategic Plan for Addressing the Recommendations of the Pancreatic Cancer Progress Review Group highlighted the need to ...

pancreatic cancer Nutritional Links to Plausible Mechanisms Underlying Pancreatic Cancer Executive Summary Nutritional Sciences Research Group and Cancer Biomarkers Research Group Division of Cancer Prevention, National Cancer Institute National Institutes of Health, Department of Health and Human Services December 3, 2002 Bethesda, Maryland Nutritional Links to Plausible Mechanisms Underlying Pancreatic Cancer Nutritional Sciences Research Group and Cancer Biomarkers Research Group Executive Summary INTRODUCTION Recent epidemiological and experimental studies suggest that pancreatic cancer may be a form of cancer that is preventable. The NCI?s 2002 Strategic Plan for Addressing the Recommendations of the Pancreatic Cancer Progress ...

ORIGINAL REPORTS Current Status of Gene Therapy for Pancreatic Cancer Pedro J. Rami´rez, MD,* and Selwyn M. Vickers, MD* † *Department of Surgery and the † Gene Therapy Program, University of Alabama at Birmingham, Birmingham, Alabama Pancreatic adenocarcinoma remains a widespread and difficult disease to treat. Surgical resection offers the possibility of cure in a select few. However, most patients are not eligible, and con- ventional chemotherapy and radiation remain largely ineffec- tive. Despite this, our understanding of the pathogenesis of the disease has advanced considerably over the past few decades. These findings provide the basis for the development of much needed new therapeutic modalities. Specifically, the application of new recombinant DNA technology and techniques to pan- creatic cancer has yielded promising results. ...

S S potlight on potlight on Keeping you informed For further information on any of the topics in this issue, fill in the Faxback form on the back. Editorial Board Zandra Clark, Ph.D. Carla Shaw-Bruha, Ph.D. Amanda Miller-Lindholm, Ph.D. Jill Hempel, M.S. Please email any comments to spotlights@transgenomic.com. Pancreatic Cancer Pancreatic Cancer To find out more, please fill out this form and fax it back to us Name: Title: Institution/Company: Department: Street Address: Postal Code: Telephone No.: Fax: Email: I am interested in (Please indicate all applicable): Novel mutation discovery Genotyping known SNPs and mutations RNA Analysis, RT-PCR and siRNA Size based separation and purification Oligo QC analysis and purification Methylation analysis ...

Smokeless and Other Noncigarette Tobacco Use and Pancreatic Cancer : A Case-Control Study Based on Direct Interviews Juan Alguacil and Debra T. Silverman Division of Cancer Epidemiology and Genetics. National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland Abstract Cigarette smoking is an important and well-established cause of pancreatic cancer . In contrast, little is known about the effects of smoking cigars, pipes, and use of smokeless tobacco on pancreatic cancer risk. The objective of the present study was to examine the association between noncigarette tobacco use ( i.e., cigars, pipes, smokeless tobacco) and pancreatic cancer risk among nonsmokers of cigarettes. A population-based case-control study of pancreatic cancer was conducted during 1986 –1989 among residents of Atlanta, ...